CN109021019B - 一种米铂的制备方法 - Google Patents
一种米铂的制备方法 Download PDFInfo
- Publication number
- CN109021019B CN109021019B CN201710434439.9A CN201710434439A CN109021019B CN 109021019 B CN109021019 B CN 109021019B CN 201710434439 A CN201710434439 A CN 201710434439A CN 109021019 B CN109021019 B CN 109021019B
- Authority
- CN
- China
- Prior art keywords
- mixture
- solvent
- miriplatin
- temperature
- myristic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- LRCTTYSATZVTRI-UHFFFAOYSA-L cyclohexane-1,2-diamine;platinum(4+);tetradecanoate Chemical compound [Pt+4].NC1CCCCC1N.CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O LRCTTYSATZVTRI-UHFFFAOYSA-L 0.000 title claims abstract description 11
- 229950004962 miriplatin Drugs 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 22
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims abstract description 16
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000021360 Myristic acid Nutrition 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 claims abstract description 15
- 229960001756 oxaliplatin Drugs 0.000 claims abstract description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 12
- 238000004321 preservation Methods 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 11
- 238000000967 suction filtration Methods 0.000 claims abstract description 11
- 238000001291 vacuum drying Methods 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000005457 ice water Substances 0.000 claims description 9
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- 238000001816 cooling Methods 0.000 abstract description 8
- 238000010438 heat treatment Methods 0.000 abstract description 5
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 4
- 238000003756 stirring Methods 0.000 abstract description 4
- 238000002425 crystallisation Methods 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 18
- 190000032366 miboplatin Chemical compound 0.000 description 17
- 229950002777 miboplatin Drugs 0.000 description 17
- 238000001914 filtration Methods 0.000 description 13
- 239000012065 filter cake Substances 0.000 description 11
- 230000003287 optical effect Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 229910052697 platinum Inorganic materials 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 229940045845 sodium myristate Drugs 0.000 description 4
- JUQGWKYSEXPRGL-UHFFFAOYSA-M sodium;tetradecanoate Chemical compound [Na+].CCCCCCCCCCCCCC([O-])=O JUQGWKYSEXPRGL-UHFFFAOYSA-M 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- -1 tetradecanoyloxy Chemical group 0.000 description 2
- SGLJYTWMWIAGEU-KGZKBUQUSA-N (1r,2r)-cyclohexane-1,2-diamine;platinum(2+) Chemical compound [Pt+2].N[C@@H]1CCCC[C@H]1N SGLJYTWMWIAGEU-KGZKBUQUSA-N 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- NWAHZABTSDUXMJ-UHFFFAOYSA-N platinum(2+);dinitrate Chemical compound [Pt+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O NWAHZABTSDUXMJ-UHFFFAOYSA-N 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710434439.9A CN109021019B (zh) | 2017-06-09 | 2017-06-09 | 一种米铂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710434439.9A CN109021019B (zh) | 2017-06-09 | 2017-06-09 | 一种米铂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109021019A CN109021019A (zh) | 2018-12-18 |
CN109021019B true CN109021019B (zh) | 2021-08-03 |
Family
ID=64629878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710434439.9A Active CN109021019B (zh) | 2017-06-09 | 2017-06-09 | 一种米铂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109021019B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116836054B (zh) * | 2023-07-20 | 2024-03-08 | 石家庄四药有限公司 | 一种十四烷酸晶型的制备方法及其晶型和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004083508A (ja) * | 2002-08-28 | 2004-03-18 | Sumitomo Chem Co Ltd | 白金錯体の製造方法 |
CN102127119B (zh) * | 2011-01-11 | 2012-03-14 | 济南利民制药有限责任公司 | 一种米铂的制备方法 |
CN102516311B (zh) * | 2011-11-03 | 2014-05-28 | 南京优科生物医药有限公司 | 一种米铂的制备方法 |
CN104119387B (zh) * | 2013-04-24 | 2017-08-18 | 正大天晴药业集团股份有限公司 | 一种米铂的制备方法 |
CN103204881A (zh) * | 2013-04-26 | 2013-07-17 | 南京华威医药科技开发有限公司 | 一种制备抗肿瘤药物米铂的新方法 |
CN104725430A (zh) * | 2013-12-23 | 2015-06-24 | 天津泰普药品科技发展有限公司 | 一种工业化生产米铂的方法 |
CN103910762A (zh) * | 2014-04-16 | 2014-07-09 | 北京美迪康信医药科技有限公司 | 一种米铂的制备方法 |
-
2017
- 2017-06-09 CN CN201710434439.9A patent/CN109021019B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN109021019A (zh) | 2018-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10882813B2 (en) | Method for the synthesis of ferric oraganic compounds | |
EP1819720B1 (en) | A cost-effective process for preparation of manufacture of iron sucrose | |
AU2007209099A1 (en) | Preparation of platinum (ll) complexes | |
US7208616B2 (en) | Cis-diiodo-(trans-L-1,2-cyclohexanediamine) platinum (II) complex and processes for preparing high purity oxaliplatin | |
CN109021019B (zh) | 一种米铂的制备方法 | |
CN100408588C (zh) | 具有低含量伴生杂质的奥沙利铂及其制备方法 | |
CN111499593A (zh) | 非布司他的合成工艺 | |
KR20180105450A (ko) | 피마살탄 콜린염 및 이의 수화물의 제조방법 | |
US10995109B2 (en) | Industrial preparation method for high-purity dicycloplatin needle-like crystal | |
EP2502625A1 (en) | Process for the preparation of crystalline levofolinic acid | |
EP2970320A2 (en) | Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain | |
CN110903252B (zh) | 一种4,6-二羟基嘧啶的制备方法 | |
CN111978185B (zh) | 一种水杨胺醋酸盐的制备方法 | |
CN108623608B (zh) | 扎布沙星中间体的制备方法 | |
CN106957311B (zh) | 雷替曲塞的溶剂化物及其制备方法 | |
CN109836341B (zh) | 一种水杨胺醋酸盐的制备方法 | |
CN105712943B (zh) | 一种卢非酰胺中间体的制备工艺 | |
CN113087680A (zh) | Dota晶型及其制备方法 | |
CN116143650A (zh) | 一种盐酸四环素的结晶方法 | |
CN112094198A (zh) | 一种n-亚硝基-n-甲基-4-氨基丁酸的合成方法 | |
CN113214321A (zh) | 一种米诺膦酸e晶型的制备方法 | |
RU2339578C1 (ru) | Способ получения висмута галловокислого основного | |
KR100749162B1 (ko) | 아세클로페낙 아미노산염의 제조방법 | |
CN111377879A (zh) | 一种l-噻唑烷-4-甲酸的制备方法 | |
CN117886819A (zh) | L-5-甲基四氢叶酸及其钙盐的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221118 Address after: 276006 No. 209 Hongqi Road, Shandong, Linyi Patentee after: LUNNAN BETTER PHARMACEUTICAL Co.,Ltd. Address before: 276005 No. 209 Hongqi Road, Shandong, Linyi Patentee before: LUNAN PHARMACEUTICAL Group Corp. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of miplatin Effective date of registration: 20230117 Granted publication date: 20210803 Pledgee: Industrial and Commercial Bank of China Limited Linyi Shizhong Sub-branch Pledgor: LUNNAN BETTER PHARMACEUTICAL Co.,Ltd. Registration number: Y2023980031096 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |